First Pacific Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-266
Closed -$11.1K 544
2024
Q4
$11.1K Hold
266
﹤0.01% 270
2024
Q3
$17.8K Hold
266
﹤0.01% 246
2024
Q2
$31.6K Hold
266
0.01% 194
2024
Q1
$28.3K Hold
266
0.01% 202
2023
Q4
$26.5K Hold
266
0.01% 205
2023
Q3
$27.5K Buy
+266
New +$29.7K 0.01% 184

Other funds holding MRNA

First Pacific Financial's MRNA Position: Q1 2025 in Review

First Pacific Financial sold out of Moderna (MRNA) in Q1 2025, closing a stake of 266 shares — an estimated $11.1K sold.

First Pacific Financial first reported a position in MRNA in Q3 2023 and held it in 6 quarters. The position peaked at $31.6K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • First Pacific Financial reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • First Pacific Financial sold 266 Moderna shares in Q1 2025, an estimated $11.1K.
  • First Pacific Financial first reported a position in Moderna in Q3 2023 and held it in 6 quarters.
  • First Pacific Financial's Moderna position peaked at $31.6K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on First Pacific Financial's 13F filing for Q1 2025, filed 23 Apr 2025.